The success of mRNA-based vaccines for COVID-19 lays the path to accelerate the development of this modality for many other diseases. Key decisions must be made early in the drug development process for all aspects: from mRNA manufacturing to sourcing of critical components such as lipid excipients for the final formulation. Doing a deep dive into the critical aspects of these lipids, this webinar aims to highlight that considerations such as excipient quality can significantly impact the performance, reproducibility, costs, and regulatory timelines of the final drug product.
In this webinar, you will discover:
- How we got to the lipid nanoparticles we have today
- Key considerations for their formulation
- What’s important to keep in mind when choosing lipid excipients for the development of your drug product